Australia Human Metapneumovirus (hmpv) Diagnostics Market Size & Outlook

The human metapneumovirus (hmpv) diagnostics market in Australia is expected to reach a projected revenue of US$ 14.5 million by 2030. A compound annual growth rate of 11.5% is expected of Australia human metapneumovirus (hmpv) diagnostics market from 2025 to 2030.
Revenue, 2024 (US$M)
$7.7
Forecast, 2030 (US$M)
$14.5
CAGR, 2025 - 2030
11.5%
Report Coverage
Australia

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Australia human metapneumovirus (hmpv) diagnostics market, 2018-2030 (US$M)

Australia human metapneumovirus (hmpv) diagnostics market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Related Markets

Australia human metapneumovirus (hmpv) diagnostics market highlights

  • The Australia human metapneumovirus (hmpv) diagnostics market generated a revenue of USD 7.7 million in 2024 and is expected to reach USD 14.5 million by 2030.
  • The Australia market is expected to grow at a CAGR of 11.1% from 2025 to 2030.
  • In terms of segment, pcr-based diagnostics was the largest revenue generating technology in 2024.
  • Microarray Technology is the most lucrative technology segment registering the fastest growth during the forecast period.


Human metapneumovirus (hmpv) diagnostics market data book summary

Market revenue in 2024USD 7.7 million
Market revenue in 2030USD 14.5 million
Growth rate11.1% (CAGR from 2025 to 2030)
Largest segmentPcr-based diagnostics
Fastest growing segmentMicroarray Technology
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPCR-Based Diagnostics, Next-Generation Sequencing (NGS), Immunofluorescence Assays, Lateral Flow Assays, Microarray Technology, Other Advanced Technologies


Other key industry trends

  • In terms of revenue, Australia accounted for 1.4% of the global human metapneumovirus (hmpv) diagnostics market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, China human metapneumovirus (hmpv) diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 32.8 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Human Metapneumovirus (hMPV) Diagnostics Market Companies

Name Profile # Employees HQ Website
DiaSorin View profile 1001-5000 Saluggia, Piemonte, Italy, Europe https://www.diasorin.com/
Abbott View profile - - -
ZeptoMetrix View profile 101-250 Buffalo, New York, United States, North America http://zeptometrix.com
R-Biopharm View profile 501-1000 Darmstadt, Hessen, Germany, Europe http://www.r-biopharm.com/
Seegene View profile 51-100 Seoul, Seoul-t'ukpyolsi, South Korea, Asia http://www.seegene.com/
ARUP Laboratories View profile 1001-5000 Salt Lake City, Utah, United States, North America http://www.aruplab.com
QuidelOrtho Corp View profile 7100 9975 Summers Ridge Road, San Diego, CA, United States, 92121 https://www.quidelortho.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com

Australia human metapneumovirus (hmpv) diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to human metapneumovirus (hmpv) diagnostics market will help companies and investors design strategic landscapes.


Pcr-based diagnostics was the largest segment with a revenue share of 54.55% in 2024. Horizon Databook has segmented the Australia human metapneumovirus (hmpv) diagnostics market based on pcr-based diagnostics, next-generation sequencing (ngs), immunofluorescence assays, lateral flow assays, microarray technology, other advanced technologies covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Australia human metapneumovirus (hmpv) diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia human metapneumovirus (hmpv) diagnostics market databook

  • Our clientele includes a mix of human metapneumovirus (hmpv) diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia human metapneumovirus (hmpv) diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia human metapneumovirus (hmpv) diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia Technology - Human Metapneumovirus (hmpv) Diagnostics Market size, 2024 - 2030 (US$M)

Australia Human Metapneumovirus (hMPV) Diagnostics Market Outlook Share, 2024 & 2030 (US$M)

Australia Technology - Human Metapneumovirus (hmpv) Diagnostics Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online